Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alli Return In U.S. Fattens Glaxo’s Consumer Outlook

This article was originally published in The Pink Sheet Daily

Executive Summary

GSK Consumer Healthcare says alli would be available starting Feb. 25 in most stores in the U.S. and Puerto Rico in “improved tamper-evident packaging.” Despite the product’s checkered history, its return marks another boost for Glaxo’s consumer outlook.


Related Content

Obesity Market Snapshot: Competition Is Good For Everyone, Especially Orexigen
Alli Recall Could Help Mitigate Reputation Damage In Face Of Tampering
Glaxo Keeps Alli As Recently Pruned Consumer Division Thrives
Alli Campaign Seeks To "Drive Behavior Change," Stresses Healthy Choices
Alli Pioneers EU Centralized Process For Nonprescription Switch


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts